Gender Dysphoria and Gender Affirming Surgery: The New York State Experience
Joshua Zhu,Emily Wang,Steven Liu,Chad Gueli,Aurora D. Pryor,A Laurie Shroyer,Aleksandra Krajewski
DOI: https://doi.org/10.1016/j.bjps.2024.02.019
IF: 3.022
2024-02-11
Journal of Plastic Reconstructive & Aesthetic Surgery
Abstract:Summary Background Transgender and gender nonconforming (TGNC) individuals experience incongruence between their self-identified gender versus their birth-assigned sex. Occasionally, TGNC patients receive gender-affirming surgical (GAS) procedures. GAS is an evolving surgical field, and there is a paucity of literature documenting patient characteristics and procedures. Addressing this knowledge gap, this retrospective cohort analysis described the characteristics of New York State's TGNC residents with gender dysphoria (GD) diagnosis, including patients receiving at least one gender affirming surgical procedure. Methods Using the 2002 – 2018 New York Statewide Planning and Research Cooperative System (SPARCS) database, patients' first-time TCNC records and their risk characteristics were identified. Patients receiving GAS procedures were sub-classified as top-only, bottom-only, or combined top/bottom procedures, and were compared to TGNC patients not receiving GAS. Results Of 24,615 TGNC SPARCS database records extracted, 11,427 (46.4%) were transmasculine (female-to-male) and 13,188 (53.6%) were transfeminine (male-to-female). Overall, 2.73% of transgender patients received at least one GAS procedure. Of these patients, 78.2% had masculinizing and 21.8% had feminizing surgeries. Post-GD diagnosis, the positive predictors for a GAS-based procedure included female birth sex, pediatric age (< 18 years) or older age (60+ years), commercial insurance coverage, and Hispanic race. In contrast, negative GAS predictors included male birth sex and government insurance coverage (i.e., Medicare and Medicaid). Conclusions Compared to transgender women, transgender men were more likely to receive at least one GAS procedure. As TGNC patients' race, ethnicity, and payor status impacted GAS treatment rates, additional research now appears warranted to examine TGNC patients' post-diagnosis GAS treatment disparities.
surgery